Altre lingue DarioHealth Corp.

Azioni

DRIO

US23725P2092

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
1,48 ^USD	+0,68%		+27,59%	-13,95%

25/04	DarioHealth Corp. pubblica un nuovo studio sottoposto a revisione paritaria che approfondisce le prove che la gestione delle condizioni cardiometaboliche in un'unica piattaforma integrata migliora i risultati clinici.	CI
18/04	DarioHealth Corp. firma due contratti con due datori di lavoro per la Suite Cardiometabolica con soluzione integrata Glp-1	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution	18/04
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	18/04
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH	03/04
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health	02/04
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	02/04
DarioHealth : Q4 and full year 2023 earnings call transcript	01/04
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results	28/03
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stocks Set for -2-	28/03
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH	21/03
North American Morning Briefing : Investors -2-	21/03
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications	12/03
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	12/03
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE	28/02
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	21/02
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions	21/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue DarioHealth Corp.

Azioni

DRIO

US23725P2092

Altre lingue

Filtri